Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites
- PMID: 25003311
- PMCID: PMC4183913
- DOI: 10.1089/dia.2014.0066
Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites
Erratum in
-
Correction.Diabetes Technol Ther. 2015 Jan;17(1):68. doi: 10.1089/dia.2014.1610. Diabetes Technol Ther. 2015. PMID: 25574594 Free PMC article. No abstract available.
Abstract
Background: The Control to Range Study was a multinational artificial pancreas study designed to assess the time spent in the hypo- and hyperglycemic ranges in adults and adolescents with type 1 diabetes while under closed-loop control. The controller attempted to keep the glucose ranges between 70 and 180 mg/dL. A set of prespecified metrics was used to measure safety.
Research design and methods: We studied 53 individuals for approximately 22 h each during clinical research center admissions. Plasma glucose level was measured every 15-30 min (YSI clinical laboratory analyzer instrument [YSI, Inc., Yellow Springs, OH]). During the admission, subjects received three mixed meals (1 g of carbohydrate/kg of body weight; 100 g maximum) with meal announcement and automated insulin dosing by the controller.
Results: For adults, the mean of subjects' mean glucose levels was 159 mg/dL, and mean percentage of values 71-180 mg/dL was 66% overall (59% daytime and 82% overnight). For adolescents, the mean of subjects' mean glucose levels was 166 mg/dL, and mean percentage of values in range was 62% overall (53% daytime and 82% overnight). Whereas prespecified criteria for safety were satisfied by both groups, they were met at the individual level in adults only for combined daytime/nighttime and for isolated nighttime. Two adults and six adolescents failed to meet the daytime criterion, largely because of postmeal hyperglycemia, and another adolescent failed to meet the nighttime criterion.
Conclusions: The control-to-range system performed as expected: faring better overnight than during the day and performing with variability between patients even after individualization based on patients' prior settings. The system had difficulty preventing postmeal excursions above target range.
Trial registration: ClinicalTrials.gov NCT01271023.
Figures
Similar articles
-
The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes.Diabetes Obes Metab. 2018 Feb;20(2):245-256. doi: 10.1111/dom.13052. Epub 2017 Aug 10. Diabetes Obes Metab. 2018. PMID: 28675686 Free PMC article. Review.
-
Multivariable adaptive closed-loop control of an artificial pancreas without meal and activity announcement.Diabetes Technol Ther. 2013 May;15(5):386-400. doi: 10.1089/dia.2012.0283. Epub 2013 Apr 1. Diabetes Technol Ther. 2013. PMID: 23544672 Free PMC article.
-
Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.J Diabetes Sci Technol. 2009 Sep 1;3(5):1031-8. doi: 10.1177/193229680900300506. J Diabetes Sci Technol. 2009. PMID: 20144416 Free PMC article.
-
Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.J Diabetes Sci Technol. 2009 Sep 1;3(5):1109-20. doi: 10.1177/193229680900300514. J Diabetes Sci Technol. 2009. PMID: 20144424 Free PMC article.
-
Glucose-responsive insulin delivery for type 1 diabetes: The artificial pancreas story.Int J Pharm. 2018 Jun 15;544(2):309-318. doi: 10.1016/j.ijpharm.2017.12.022. Epub 2017 Dec 16. Int J Pharm. 2018. PMID: 29258910 Review.
Cited by
-
A Review of Safety and Design Requirements of the Artificial Pancreas.Ann Biomed Eng. 2016 Nov;44(11):3158-3172. doi: 10.1007/s10439-016-1679-2. Epub 2016 Jun 28. Ann Biomed Eng. 2016. PMID: 27352278 Free PMC article. Review.
-
Artificial Pancreas Device Systems for the Closed-Loop Control of Type 1 Diabetes: What Systems Are in Development?J Diabetes Sci Technol. 2016 May 3;10(3):714-23. doi: 10.1177/1932296815617968. Print 2016 May. J Diabetes Sci Technol. 2016. PMID: 26589628 Free PMC article. Review.
-
The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes.Diabetes Obes Metab. 2018 Feb;20(2):245-256. doi: 10.1111/dom.13052. Epub 2017 Aug 10. Diabetes Obes Metab. 2018. PMID: 28675686 Free PMC article. Review.
-
A physiology-based model describing heterogeneity in glucose metabolism: the core of the Eindhoven Diabetes Education Simulator (E-DES).J Diabetes Sci Technol. 2015 Mar;9(2):282-92. doi: 10.1177/1932296814562607. Epub 2014 Dec 18. J Diabetes Sci Technol. 2015. PMID: 25526760 Free PMC article.
-
The Artificial Pancreas in 2016: A Digital Treatment Ecosystem for Diabetes.Diabetes Care. 2016 Jul;39(7):1123-6. doi: 10.2337/dc16-0824. Diabetes Care. 2016. PMID: 27330124 Free PMC article. No abstract available.
References
-
- Juvenile Diabetes Research Foundation: Emerging technologies in diabetes research. The JDRF e-Newsletter 2006; (Sept):10
-
- O'Grady MJ, Retterath AJ, Keenan DB, Kurtz N, Cantwell M, Spital G, Kremliovsky MN, Roy A, Davis EA, Jones TW, Ly TT: The use of an automated, portable glucose control system for overnight glucose control in adolescents and young adults with type 1 diabetes. Diabetes Care 2012;35:2182–2187 - PMC - PubMed
-
- Steil GM, Rebrin K, Darwin C, Hariri F, Saad MF: Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes 2006;55:3344–3350 - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous